Abstract
Purpose
To investigate the effects of various intervention approaches on cancer-related fatigue (CRF) in patients with breast cancer.
Method
Computer searches were conducted on PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Wanfang databases from their establishment to June 2023. Selection was made using inclusion and exclusion criteria, and 77 articles were included to compare the effects of 12 interventions on patients with breast cancer.
Results
Seventy-seven studies with 12 various interventions were examined. The network findings indicated that cognitive behavioral therapy (CBT) (SMD, -1.56; 95%CI, -3.08~-0.04), Chinese traditional exercises (CTE) (SMD, -0.85; 95%CI, -1.34~-0.36), aerobic exercise (AE) (SMD, -0.77; 95%CI, -1.09~-0.45), multimodal exercise (ME) (SMD, -0.75; 95%CI, -1.26~-0.25), music interventions (MI) (SMD, -0.74; 95%CI, -1.45~-0.03), and yoga (YG) (SMD, -0.44; 95%CI, -0.83 to -0.06) can reduce CRF more than the control group (CG). For relaxation exercises (RE) (MD, -6.69; 95%CI, -9.81~-3.57), MI (MD, -5.45; 95%CI, -7.98~-2.92), AE (MD, -4.34; 95%CI, -5.90~-2.78), ME (MD, -3.47; 95%CI, -4.95~-1.99), YG (MD, -2.07; 95%CI, -3.56~-0.57), and mindfulness training (MD, -1.68; 95%CI, -2.91~-0.46), PSQI improvement was superior to CG. In addition, for CTE (MD, 11.39; 95%CI, 4.11-18.66), YG (MD, 11.28; 95%CI, 1.63-20.93), and AE (MD, 9.34; 95%CI, 0.26~18.42), Functional Assessment of Cancer Therapy-Breast improvement was superior to CG.
Conclusion
Cognitive behavioral therapy (CBT) is the most effective measure for alleviating CRF in patients with breast cancer and Relaxation exercises (RE) is the most effective measure for improving sleep quality. In addition, Chinese traditional exercises (CTE) is the best measure for enhancing quality of life. Additional randomized controlled trials (RCTs) are expected to further investigate the efficacy and mechanisms of these interventions.
Systematic review registration
https://www.crd.york.ac.uk/prospero/, identifier CRD42023471574.
Keywords: breast cancer, CFR, network meta-analysis, cancer, systematic review
Introduction
Breast cancer is the most common cancer in women. The American Cancer Society reports a yearly increase of 0.5% in the incidence of breast cancer in women. The projection for 2022 estimates approximately 287,850 new cases of breast cancer in women in the United States, accounting for 31% of all new cancer diagnoses in women (1). In recent years, the survival rate of patients has improved due to the emergence of neoadjuvant therapy. However, survivors face a series of physical and mental problems, such as premature menopause, body image disorder, fatigue, and depression (2–4). Patients with breast cancer commonly experience cancer-related fatigue (CRF) as one of the most common symptoms (5). Before undergoing anticancer treatment, women with breast cancer may have already experienced fatigue. The occurrence of CRF is closely connected to the factors inherent to the primary tumor, which may be associated with the abnormal expression of certain substances released by the cancer cells in the patient, such as IL1, IL6, and TNF-a interferon. The severity of fatigue is proportional to the amount of interleukin released by tumor cells into the blood (6). When starting treatment, between 60% and 90% of women with breast cancer may experience fatigue (7). Severe fatigue is experienced by approximately a quarter of breast cancer survivors (8). An increase in the burden on patients’ families and caregivers can be caused by CRF. In addition, the time it takes for patients to return to work early after cancer treatment may be prolonged by CRF (9–13).
In recent years, there has been a growing interest in investigating CRF for breast cancer. The effects of aerobic exercise (AE), resistance exercise, relaxation training, yoga (YG), music, and other intervention methods on CRF in patients with breast cancer have been investigated in previous studies. Traditional meta-analyses have also demonstrated the effectiveness of YG and resistance training (RT) in reducing CRF in patients with breast cancer (14, 15). Olsson et al. offered a comprehensive overview of the effects of rehabilitation interventions and discovered that CRF was positively affected by exercise and YG (16). Health-related quality of life in breast cancer survivors can be significantly impaired by the occurrence of CRF. Practical exercise training can enhance mitochondrial function and plasticity in patients, thereby improving the occurrence of CRF (17–19). However, evidence-based recommendations regarding the most effective type of intervention for improving CRF in patients with breast cancer are still lacking. Therefore, it is crucial to identify a suitable intervention for reducing CRF among complex interventions in patients with breast cancer.
Network meta-analysis (NMA), also called meta-analysis of mixed treatment comparisons or multiple treatment comparisons (20), offers a method to compare the size of the impact of various intervention types on CRF in patients with breast cancer by estimating direct and indirect comparisons. Although two previously published NMA studies were identified (21, 22), the study only reported on the effects of various exercise interventions, and no further studies were conducted on other intervention types. Consequently, this study aims to conduct an NMA on relevant randomized controlled trials (RCTs) to compare the effects of various interventions on CRF in patients with breast cancer. The findings of this study are crucial for developing clinical practice guidelines recommending the best intervention to improve the outcome of CRF in patients with breast cancer.
Methods
This NMA was designed based on the guidelines for Preferred Reporting Items of Systematic Review and Network Meta-Analysis (23), which are registered in the PROSPERO database (CRD42023471574).
Search strategies
Searches for RCT-related studies on CRF in breast cancer, published up to July 2023, were conducted using databases such as PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure, and Wanfang. The search involved a combination of subject and free words. The search strategy can be found in Additional Document 1 (Appendix 1).
Study selection
In this study, YL and LG were selected as independent reviewers to screen the titles and abstracts of the retrieved literature using search strategies to identify literature that met the inclusion criteria. In case of disagreement, checks and discussions were performed by XA C to reach a consensus. Duplicate data were de-duplicated using EndNote software (24). A full-text assessment of potentially eligible studies was conducted based on the inclusion and exclusion criteria. Any differences between the reviewers were resolved through discussion, and EndNote software was used to manage this phase.
Inclusion criteria
Studies that met the following criteria were included (1): Study type: RCT (2). Studies that included adult patients (18 years or older) diagnosed with breast cancer that were not limited to cancer stage and current treatment options for breast cancer (3); Interventions: AE, RT, Chinese traditional exercises (CTE), other exercise (OE), multimodal exercise (ME), YG, stretching exercise (STE), music interventions (MI), cognitive behavioral therapy (CBT), mindfulness training (MT), and relaxation exercises (RE); and (4) Outcomes: at least one outcome measure. The primary outcome measure was CRF assessed using the Functional Assessment of Cancer Therapy (FACT)-Fatigue Scale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQC30), Piper Fatigue Scale (PFS), Schwartz Cancer Fatigue Scale (SCFS), and Multidimensional Fatigue Inventory (25). The secondary outcomes were sleep quality versus quality of life as measured using the Pittsburgh Sleep Quality Index (PSQI) and Functional Assessment of Cancer Therapy-Breast (FACT-B). Each intervention is defined in Additional Document 1 (Appendix 2). Each outcome measure is defined in Additional Document 1 (Appendix 3).
Exclusion criteria
(1) Patients with severe complications (2). Studies with outcomes that did not align with the design of this study (3). Studies with data that could not be integrated, such as incorrect or incomplete information.
Data extraction
The reviewers independently extracted the following data: first author, publication year, country, sample size, body mass index (BMI), age, weight, height, weight, intervention, tumor stage, intervention time, intervention frequency, and outcome indicators. Data are presented as mean ± standard deviation.
Risk of bias assessment
Two reviewers (LG and ZR Z) independently assessed the risk of bias, and a third reviewer adjudicated using Cochrane collaboration tools, such as sequence generation, assignment hiding, blinding, incomplete outcome data, non-selective outcome reporting, and other sources of bias (26). Each criterion was judged to have a low, unclear, or high risk of bias (27).
Data analysis
The “Netmeta” package (28) in R-4.2.1 software (29) was used for NMA. Network plots were generated using the STATA 15.1 “network plot” feature to describe and present various forms of motion. Nodes were used to represent various interventions, and edges were used to depict favorable intervention comparisons. Inconsistencies between direct and indirect comparisons were evaluated using the node segmentation method (30). Combined estimates and 95% confidence intervals (95% CI) were computed using random effects network element analysis. In studies where the same unit of measurement was of interest, the mean difference (MD) was considered a treatment effect when analyzing the results or evaluating the standardized mean difference (SMD). Different exercise treatments were compared using a pairwise randomized effects meta-analysis. The heterogeneity of all pair-to-pair comparisons was evaluated using the I2 statistic, and publication bias was evaluated using the p-value of Egger’s test. Publication bias and secondary study effects, analyzed by the results of more than a dozen reported studies, were identified using funnel plots.
Results
Literature selection
After removing duplicates, 4006 records were retrieved, and 3624 papers were discarded. The full text of the remaining 382 records was analyzed, and 305 cases did not satisfy the inclusion criteria: inconsistent intervention measures (172), inconsistent outcome indicators (31), data deficiency (9), and duplicate study (8). In the end, 77 (32–108) studies were included. Figure 1 shows the research flowchart. Articles from the full-text evaluation and the reasons for their exclusion are provided in Additional Document 1 (Appendix 8).
Figure 1.
Flow of trials through the review.
Study and participant characteristics
Studies comparing the effects of 12 various interventions on patients with breast cancer, published between 2001 and 2022, were included. The intervention durations ranged from 1 week to 12 months, and a total of 5,254 patients were reported in the included studies. Among these studies, 62 reported CFR, 23 reported PSQI, and 17 reported FACT-B. The participants had an average age of 18-73 years, an average BMI of 21.06 ± 2.26-72.3 ± 13.1, an average height of 145.64 ± 24.07-170.2 ± 5.4 cm, and an average weight of 54.74± 6.66-74.3 ± 17.0 Kg.
Table 1 shows the characteristics of the studies and participants. The risk of bias assessment for each study is presented in Additional Document 1 (Appendix 4), and Figure 2 presents the aggregated data.
Table 1.
General characteristics of all included studies.
| Name | Years | Country | Group | Age | BMI | Height(cm) | Weight(kg) | Tumor staging | Sample size | Intervention time | Intervention frequency | Outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gokal (32) | 2016 | UK | AE/CG | 52.08 ± 11.7/ 52.36 ± 8.9 |
27.20 ± 4.82/ 28.25± 5.83 |
NA | NA | I-III | 25/25 | 12weeks | 5 times a week, >20min/times |
FACT-F |
| Pinto (33) | 2005 | USA | AE/CG | 53.14 ± 9.70 | 27.01 ± 4.65/ 28.26± 5.33 |
NA | NA | 0-II | 43/43 | 12weeks | > 30 minutes, 5 days a week | Linear analog scale for fatigue) |
| Mock (34) | 2005 | USA | AE/CG | 51.3± 8.9/ 51.6 ± 9.7 |
25.5± 4.0 25.8± 5.1 |
NA | NA | 0–III | 54/54 | 6weeks | > 60 minutes per week | PFS |
| Husebø (35) | 2014 | Norway | AE/CG | 50.8 ± 9.7/ 53.6 ± 8.8 |
NA/NA | NA/NA | 69.0 ± 11.6/ 72.0 ± 15.7 |
I–III | 33/34 | 15 weeks | 30 minutes/day | SCFS-6 |
| Mock (36) | 2001 | USA | AE/CG | 48.64 ± 10.69/ 27.95 ± 5.94 |
23.86 ± 3.94/ 27.95 ± 5.94 |
145.64 ± 24.07/ 168.59 ± 35.10 |
65.54 ± 2.47/ 65.18 ± 2.68 |
I-IIIa | 28/22 | NA | > 90 minutes per week | PFS |
| Wang (37) | 2011 | USA | AE/CG | 48.40 ± 10.15/ 52.3± 8.84 |
NA/NA | 156.86± 5.04/ 156.74± 4.45 |
55.68 ± 6.91/ 54.74± 6.66 |
I-II | 30/32 | 6weeks | 3-5 times a week | FACT-F/PSQI |
| Schmidt (38) | 2015 | Germany | RT/RE | 52.2 ± 9.9/ 53.3 ± 10.2 |
25.7 ± 4.6/ 26.3 ± 4.9 |
NA/NA | NA/NA | 0–III | 49/46 | 12weeks | Twice a week | EORTC QLQ30-Fatigue |
| Steindorf (39) | 2014 | Germany | RT/RE | 55.2 ± 9.5/ 56.4 ± 8.7 |
26.9 ± 5.4/ 27.6 ± 4.8 |
NA/NA | NA/NA | 0–III | 80/80 | 12weeks | 2 times/week | EORTC QLQ30 |
| Han (40) | 2019 | China | CTE/CG | 46.39 ± 5.79/45.52 ± 6.50 | NA/NA | NA/NA | NA/NA | I-III期 | 23/21 | 12weeks | 2 times/day, 5 days/week | PFS-R |
| Yang (41) | 2022 | China | CTE/CG | NA/NA | NA/NA | NA/NA | NA/NA | I-III | 43/43 | 12weeks | 20 minutes/time, 2 times/day, 5 days/week |
PFS-R/FACT-B |
| Hui (42) | 2022 | China | CTE/CG | 69.51 ± 5.73 | NA/NA | NA/NA | NA/NA | I-III | 49/49 | 6 months | 2 times/day, 20 minutes/time | CFS/PSQI/FACT-B |
| Xie (43) | 2022 | China | OE/AE | 18∼50 | 22.05± 2.67/ 22.07± 3.08 |
NA/NA | NA/NA | I-IV | 45/45 | Four cycles of chemotherapy | 3 ~ 4 times/week, 30 ~ 40 min/time | CFS |
| Xu (44) | 2012 | China | AE/CG | 47.3±12.8 | NA | NA | NA | NA | 39/39 | 8weeks | 20- 30 minutes/time | RPFS |
| Hao (45) | 2013 | China | AE/CG | 46 ± 11.13/48 ± 11.32 | NA | NA | 63.74 ± 8.52/ 60.29 ± 8.26 |
I-III | 28/28 | 15weeks | For the first 3 weeks, 3 times a week, 15min each time, then increase by 5min every 3 weeks, and reach 35min in 13-15 weeks. | RPFS |
| Mijwel S (46) | 2018 | Sweden | AE/CG | 54.4± 10.3/ 52.6 ± 10.2 |
NA | 165.3 ± 6.6/ 166.4± 7.0 |
67.7 ± 13.0/ 69.1± 11.0 |
I-III | 70/60 | 16weeks | Twice a week | CRF |
| Cohen (47) | 2021 | USA | ME/AE/RE | 59.71 ± 6.99/58.56 ± 10.41/ 53.62± 8.03 |
28.21± 5.39/ 26.04 ± 3.91/ 27.93± 6.35 |
158.2 ± 40.65/ 140.2 ± 23.07/ 162.08 ± 38.90 |
64.00 ± 1.93/ 63.46 ± 2.78/ 64.58 ± 2.64 |
I-III | 13/14/13 | NA | 90min, three times/week. | PFS |
| Courneya (48) | 2007 | Canada | AE/RT/CG | 49/49.5/49 | 26.7 ± 5.6/ 26.1 ± 5.5/ 27.1 ± 5.4 |
NA | 69.4 ± 13.3/ 69.7 ± 14.4/ 72.6 ± 15.2 |
I-III | 78/82/82 | 17weeks | Three times/week | FACT-F |
| Moadel (49) | 2007 | USA | YG/CG | 55.11 ± 10.07/54.23 ± 9,81 | NA | NA | NA | I-IV | 108/56 | 12weeks | 12sessions/week, 90minutes/session | FACIT-F |
| Bower (50) | 2012 | USA | YG/CG | 54.4 ± 5.7/ 53.3 ± 4.9 |
NA | NA | NA | 0-II | 16/15 | 12weeks | Twice/week, 90 minutes/time | FSI/PSQI |
| Vadiraja (51) | 2017 | India | YG/CG | 50.54± 8.53 | NA | NA | NA | NA | 33/31 | 3 months | NA | FSI |
| Vardar (52) | 2015 | Turkey | ME/AE | 49.89 ± 4.65/47.38 ± 7.57 | 29.16 ± 5.74/29.27 ± 5.92 | NA | NA | I-II | 19/21 | 6weeks | 30 minutes/day, 3 days/week | EORTC QOL-C30 -Fatigue |
| Cramer (53) | 2015 | Germany | YG/CG | 48.3 ± 4.8/ 50.0 ± 6.7 |
NA/NA | 169.9 ± 7.3/ 170.2 ± 5.4 |
69.8 ± 11.9/ 74.3 ± 17.0 |
I-III | 19/21 | 12weeks | 90min/week | FACIT-F/FACT -B |
| Vadiraja (54) | 2009 | India. | YG/CG | NA | NA | NA | NA | II-III | 44/44 | 6weeks | > 3 times/week | EORTC QoL C30 Fatigue |
| Chaoul (55) | 2018 | USA | YG/SE/CG | 49.5 ± 9.8/ 50.4 ± 10.3/ 49 ± 10.1 |
NA | NA | NA | I–III | 74/68/85 | 12weeks | 75-90min/time | BFI/PSQI |
| Lötzke (56) | 2016 | YG/CG | YG/CG | 51.0 ± 11.0/ 51.4 ± 11.1 |
NA | NA | NA | NA | 45/47 | 12weeks | 60 minutes/week | EORTC QLQ-C30 Fatigue |
| Banasik (57) | 2011 | USA | YG/CG | 63.33 ± 6.9/ 62.4 ± 7.3 |
NA | NA | NA | II-IV | 9/9 | 8weeks | 90 minutes/time | Fatigue Likert Scale |
| Strunk (58) | 2018 | Germany | OE/CG | 54.2 ± 7.8/ 51.5 ± 8.4 |
NA | NA | NA | NA | 30/21 | 24weeks | Twice/week, 90 minutes/time | QLQ-C30 Fatigue |
| Danhauer (59) | 2009 | USA | YG/CG | 54.3 ± 9.6 /57.2 10.2 |
NA | NA | NA | Ductal carcinoma in situ -IV | 13/14 | 10weeks | 75 minutes/10 weeks | FACT-F/PSQI/FACT-B |
| Jong (60) | 2018 | Netherlands | YG/CG | 51 ± 8/ 51 ± 7.3 |
NA | NA | NA | I-III | 47/36 | 12weeks | Once a week | EORTC QLQ-C30, Fatigue |
| Wang (61) | 2014 | China | YG/CG | 18~60 | NA | NA | NA | NA | 40/42 | 4 months | 4 times/week, 1 time/day, 50min/time |
CFS |
| Zeng (62) | 2017 | China | MI/YG/CG/ME | NA | NA | NA | NA | NA | 20/24/23/22 | 4 months | Once/two days, 30 min/once, once/two days, 40 min/once, NA, once/two days, 40 min/once | CFS |
| Xiang (63) | 2017 | China | MI/YG/ME/CG | 18~60 | NA | NA | NA | NA | 20/22/24/23 | 16weeks | Once every 2 days, 30 min/every 2 days, 40min/every 2 days, 40min/NA each time | CFS |
| Yang (64) | 2020 | China | ME/CG | 49.17 ± 13.24/49.24 ± 12.09 | NA | NA | NA | NA | 79/83 | 1 month | 2-5 times/week | PFS-R |
| Liu (65) | 2018 | China | AE/CG | 55.2± 2.3/ 51.2± 3.2 |
NA | NA | NA | NA | 30/30 | 5weeks | The first 4 weeks, 15 min/day, from the fifth week after 30 min, > 3 times/week | PFS-R |
| Li (66) | 2019 | China | AE/CG | 48.0± 11.0/47.0 ± 10.0 | NA | NA | NA | NA | 46/46 | 1weeks | NA | PFS-R |
| Liu (67) | 2015 | China | AE/CG | 18-62 | NA | NA | NA | NA | 34/35 | 8weeks | 15 min/day for the first 4 weeks, 30 min/day for the last 4 weeks, > 3 times/week. |
CRF/PSQI |
| Yu (68) | 2020 | China | AE/CG | 44.01 ± 2.11/ 44.25 ± 2.24 |
NA | NA | NA | NA | 44/44 | 6weeks | 30min/each time, 4 times/week, | PFS-R |
| Chang (69) | 2016 | China | ME/CG | 42.59 ± 6.37 | NA | NA | NA | I=IV | 51/49 | 18weeks | ME: 2-3times/day, | PSQI |
| Yu (70) | 2021 | China | YG/CG | 38.8 ± 10.9/ 39.5 ± 10.3 |
NA | NA | NA | II-III | 59/59 | 8weeks | Twice/day, 3 ~ 5 times/week | CFS |
| Yang (71) | 2022 | China | AE/CG | 45. 56 ± 2. 37/ 45. 32 ± 2. 18 |
NA | NA | NA | NA | 32/32 | During chemotherapy | 30 min/day, > 3 times/week | PFS-R/PSQI |
| Zhang (72) | 2020 | China | MI/CG | 48.4 ± 8.19/ 45.48 ± 5.64 |
NA | NA | NA | I-IV | 40/40 | 3 months | 15 to 30 min/time | PFS-R/PSQI |
| Bolam (73) | 2019 | Sweden | RT/CG/AE | 52.7 ± 10.3 /24.6 ± 4.8/ 24.8 ± 4.4 |
25.1 ± 4.3/ 24.6 ± 4.8/ 24.8 ± 4.4 |
NA | NA | I–IIIa | 74/60 | 6weeks | 60 minutes/time, twice a week | CRF |
| Park (74) | 2020 | Japan | ME/CG | 53.21 ± 8.4/54.19 ± 9.27 | NA | NA | NA | 0-III | 35/36 | 8weeks | 20-45 min/day | BFI |
| Paulo (75) | 2018 | Brazil | MI/SE | 63.2 ± 7.1/ 66.6 ± 9.6 |
66.9 ± 10.3/ 72.3 ± 13.1 |
154.1 ± 6.7/ 153.1 ± 4.5 |
NA | I-III | 18/15 | 9 months | 45 minutes, 3 times a week/2 times a week. | EORTC QLQ-BR23 Fatigue |
| Wang (76) | 2022 | China | CTE/CG | NA | 22.15 ± 3.33/21.06 ± 2.26 | NA | NA | NA | 10/10 | 16weeks | 3 times/week, 40min/each time | PFS-R |
| Wei (77) | 2022 | China | CTE/CG | 40-75/ 40-75 |
22.86 ± 2.55/23.26 ± 2.56 | NA | NA | I∼III | 35/35 | 12weeks | 5 times/week, 30min/each time | MFSI-SF/FACT-B |
| Schad (78) | 2013 | Germany | AE/CG | 61.7± 9.4/ 59.3± 11.0 |
NA | NA | NA | I-III | 30/30 | 6weeks | One hour per week | CFS/PSQI |
| Liao (79) | 2022 | China | CTE/CG | 53.12± 7.02/54.63± 8.44 | 22.14± 2.67/ 23.37± 3.92 |
NA | NA | I–III | 33/35 | 12weeks | 2 times/week, 90 minutes/week | EORTC QLQ-C30-Fatigue/PSQI |
| Boing (80) | 2017 | Brazil | AE/CG | 54.1 ± 7.6 | NA | NA | NA | NA | 8/11 | 12weeks | twice a week, 60 minutes/time | PFS-R |
| Naraphong (81) | 2014 | Thailand | ME/CG | 46.36± 9.37/47.17± 6.87 | NA | NA | NA | I–IIIa | 11/12 | 10weeks | 3-5 days/week | CRF |
| Irwin (82) | 2017 | USA | CTE/CBT | 59.6 ± 7.9/ 60.0 ± 9.3 |
25.6 ± 4.5/ 26.2 ± 5.9 |
NA | NA | NA | 38/42 | 3 months | 120 times per week | PSQI/MFSI-SF |
| Chen (83) | 2013 | China | CTE/CG | 45.3 ± 6.3/ 44.7 ± 9.7 |
NA | NA | NA | 0-III | 49/46 | 3 months | 40 minutes, 5 times a week | BFI/PSQI |
| Huang (84) | 2016 | China | CTE/CG | NA | NA | NA | NA | NA | 31/33 | 12 weeks | 30 minutes/time | EFS |
| Cao (85) | 2016 | China | MT/CG | 35.45 ± 9.21/36.12 ± 9.67 | NA | NA | NA | I-III | 100/ 100 |
8weeks | 45min/days | CFS |
| Jiang (86) | 2019 | China | ME/CG | 43.48 ± 9.72/42.63 ± 9.56 | NA | NA | NA | I-III | 58/50 | 4weeks | 2 times/day, 20min/each time | PSQI/CFS |
| Fan (87) | 2021 | China | MT/CG | 46.32 ± 5.69 /45.26 ± 5.42 |
NA | NA | NA | I-III | 90/90 | 5weeks | 2 ~ 3 h/time | PFS-R/PSQI |
| Wang (88) | 2021 | China | MT/CG | 49. 15 ± 8. 39/51. 00 ± 9. 94 | NA | NA | NA | I-III | 41/43 | 6weeks | Once a week, 30 ~ 60min/time | CFS/PSQI |
| Bower (89) | 2015 | USA | MT/CG | 46.1/47.7 | NA | NA | NA | 0-III | 39/32 | 6weeks | 6 times a week | FSI/PSQI |
| Reich (90) | 2014 | USA | MT/CG | 58.0 ± 10.3/ 58.2 ± 9.5 |
NA | NA | NA | 0- III | 17/24 | 6weeks | 15-45 min/day | Fatigue |
| Rahmani (91) | 2015 | Iran | MT/CG | 43.25± 3.07/44.08± 3.28 | NA | NA | NA | l-III | 12/12 | 8weeks | Once/week, 2 hours/time | FSS |
| Lengacher (92) | 2016 | USA | MT/CG | 56.5 ± 10.2/57.6 ± 9.2 | NA | NA | NA | 0-III | 167/155 | 6weeks | 6 days/week | FSI/PSQI |
| Daley (93) | 2007 | Daley | AE/CG | 51.6 ± 8.8/50.6 ± 8.7 | 28.5 ± 4.4/27.6 ± 4.1 | NA/NA | 77.2 ± 12.1/73.9 ± 11.3 | NA | 34/38 | 8weeks | 3 times/week | RPFS/FACT-B |
| Wang (94) | 2017 | China | CTE/CG | 50.5 | NA | NA | NA | I-III | 45/41 | 3 months | 20 minutes/time | CFS/PSQI |
| Li (95) | 2019 | China | YG/CG | 47.5 ± 8.2/46.7 ± 9.5 | NA | NA | NA | NA | 45/45 | 2 months | 60 min/time, 3 times/week | PSQI |
| Xiong (96) | 2019 | China | ME/CG | 51.8 ± 4.8/ 51.5 ± 4.6 |
NA | NA | NA | NA | 49/49 | During chemotherapy | 2 times/daily. 3 times/week | PSQI/FACT-B |
| Yuan (97) | 2020 | China | RE/AE | 47.87± 11.94/ 45.13± 10.77 |
24.02± 2.11/ 24.07± 2.52 |
NA | NA | I-III | 47/47 | 12weeks | RE: It was performed once every 1d, 15 min/time AE:3times/week, 15-40 minutes/time |
PSQI |
| Zhuang (98) | 2021 | China | CTE/CG | 35-50 | NA | NA | NA | NA | 70/70 | 12weeks | The first week 10min/time, 3 times/week, the second week extended to 10-20min/time, 4 times/week; Time in the third week 10-20min/time, 5 times/week. | PSQI |
| Liu (99) | 2022 | China | YG/CG | NA | 24.71 ± 3.69/23.69 ± 3.16 | NA | NA | I-II | 61/62 | 8weeks | 90 minutes/week | FACT-B |
| Stan (100) | 2016 | USA | YG/SE | 61.4 ± 7.0/ 63.0± 9.3 |
NA | NA | NA | 0-II | 18/16 | 12weeks | > 3 times/week | FACT-B |
| Rogers (101) | 2015 | USA | AE/CG | 54.9 ± 9.3/ 53.9 ± 7.7 |
NA | NA | NA | I-III | 105/112 | 3 months | > 3 times/week | FACT-B |
| Dieli (102) | 2018 | USA | ME/CG | NA | BMI≥25.0 | NA | NA | 0-III | 50/50 | 16weeks | > 3 times/week | FACT-B |
| Jin (103) | 2017 | China | YG/CG | 55∼73 | NA | NA | NA | NA | 50/50 | 16weeks | 3 times/week, 1 h/each time |
FACT-B |
| Du (104) | 2019 | China | AE/CG | 50.1 ± 3.84/50.8 ± 3.00 | 23.17 ± 3.01/23.93 ± 2.79 | NA | NA | I-III | 40/40 | 4weeks | 3 times/day, 20 minutes/time | FACT-B |
| Li (105) | 2017 | China | CTE/CG | 47.31 ± 9.85/45.43 ± 10.94 | NA | NA | NA | 0-III | 31/30 | 3 months | Once/day, 5day/week | FACT-B |
| Odynets (106) | 2019 | Ukraine | OE/YG/CTE | 59.40 ± 1.24/59.10 ± 1.37 | NA | NA | NA | NA | 45/30 | 12 months | 3 times/week, 60 minutes/day | FACT-B |
| Fong (107) | 2013 | China | CG/CTE | 58.3 ± 10.1/53.8 ± 4.2 | NA | 155.5 ± 4.3/156.7 ± 6.0 | 50.4 ± 7.4/55.6 ± 8.8 | NA | 12/16 | 6 months | 3 times/week, 60 minutes/time | FACT-B |
| Loh (108) | 2014 | Malaya | AE/AE | 18-65 | NA | NA | NA | I-II | 32/31 | 8 weeks | Twice a day/twice a week | FACT-B |
Tai Chi (TC), Yoga (YG), Music interventions (MI), Aerobic exercise (AE), Relaxation training (RE), Cognitive behavioral therapy (CBT), Mindfulness training (MT), Sling exercise (SE), Qigong (QG), Baduanjin exercise (BE), Stretching exercise (STE), Resistance training (RT), Other exercise (OE), Chinese traditional exercises (CTE), CTE (TC, QG, BE), Multimodal exercise (ME), Control group (CG).
NA, Not Applicable.
Figure 2.
Percentage of studies examining the efficacy of interventions in patients with breast cancer with low, unclear, and high risk of bias for each feature of the Cochrane Risk of Bias Tool.
Outcomes
CRF
A total of 62 (32–94) studies, involving 5385 participants, assessed CRF. In the NMA, 12 interventions were included (Figure 3A): AE, CG, RT, RE, CTE, OE, ME, YG, SE, MI, CBT, and MT. Superior CFR improvement compared with CG was observed for CBT (SMD, -1.56; 95%CI, -3.08~-0.04), CTE (SMD, -0.85; 95%CI, -1.34~-0.36), AE (SMD, -0.77; 95%CI, -1.09~-0.45), ME (SMD, -0.75; 95%CI, -1.26~-0.25), MI (SMD, -0.74; 95%CI, -1.45~-0.03), and YG (SMD, -0.44; 95%CI, -0.83 to -0.06) (Figure 4A). Comparison of adjusted funnel plots did not provide evidence of significant publication bias, as confirmed by Egger’s test (P = 0.085) (Additional Document 1: Appendix 5.1). Heterogeneity, intransitivity, and inconsistencies in network meta-analyses were also evaluated (Additional Reference 1: Appendix 6.1). Furthermore, direct comparisons of the CRF were assessed. (Additional Reference 1: Appendix 7.1).
Figure 3.

Network plots: Tai chi (TC), Yoga (YG), Music interventions (MI), Aerobic exercise (AE), Relaxation training (RE), Cognitive behavioral therapy (CBT), Mindfulness training (MT), Sling exercise (SE), Qigong (QG), Baduanjin Exercise (BE), Stretching exercise (STE), Resistance training (RT), Other exercise (OE), Chinese traditional exercises (CTE), CTE (TC, QG, BE), Multimodal exercise (ME), Control group (CG). (A) is network plots of CRF. (B) is network plots of Sleep quality. (C) is network plots of Quality of Life. The size of the nodes represents the number of times the exercise appears in any comparison of that treatment, and the width of the edges represents the total sample size in the comparisons it connects.
Figure 4.
League tables of outcome analyses: Tai chi (TC), Yoga (YG), Music interventions (MI), Aerobic exercise (AE), Relaxation training (RE), Cognitive behavioral therapy (CBT), Mindfulness training (MT), Sling exercise (SE), Qigong (QG), Baduanjin Exercise (BE), Stretching exercise (STE), Resistance training (RT), Other exercise (OE), Chinese traditional exercises (CTE), CTE (TC, QG, BE), Multimodal exercise (ME), Control group (CG). (A) is the results of CRF's network meta-analysis. (B) is the results of Sleep quality's the network meta-analysis. (C) is the results of Quality of Life's the network meta-analysis. Data are mean differences and 95% credibility intervals for continuous data.
Sleep quality
In 23 (37, 42, 50, 55, 59, 67, 69, 71, 72, 78, 79, 82, 83, 86–89, 92, 94–98) studies, PSQI was assessed in 2334 participants. Eleven interventions were included in the NMA (Figure 3B): RE, MI, AE, ME, YG, MT, SE, CTE, OE, and CG. PSQI improvement was superior to YG for RE (MD, -4.62; 95%CI, -8.08~-1.16), MI (MD, -3.38; 95%CI, -6.33~-0.44), and AE (MD, -2.27; 95%CI, -4.43~-0.11). In addition, PSQI improvement was superior to MT for RE (MD, -5.01; 95%CI, -8.36~-1.66), MI (MD, -3.77; 95%CI, -6.58~-0.95), and AE (MD, -2.66; 95%CI, -4.64~-0.67). RE (MD, -6.14; 95%CI, -10.19~-2.09), MI (MD, -4.90; 95%CI, -8.52~-1.28), and AE (MD, -3.79; 95%CI, -6.81~-0.77) demonstrated superior PSQI improvement compared with SE. Furthermore, PSQI improvement was superior to CTE for RE (MD, -6.29; 95%CI, -9.60~-2.98), MI (MD, -5.05; 95%CI, -7.82~-2.28), AE (MD, -3.94; 95%CI, -5.86~-2.02), and ME (MD, -3.08; 95%CI, -4.93~-1.22). RE (MD, -6.69; 95%CI, -10.85~-2.52), MI (MD, -5.45; 95%CI, -9.20~-1.70), AE (MD, -4.34; 95%CI, -7.51~-1.16), and ME (MD, -3.47; 95%CI, -6.61~-0.34) demonstrated superior PSQI improvement compared to OE. Additionally, RE (MD, -6.69; 95%CI, -9.81~-3.57), MI (MD, -5.45; 95%CI, -7.98~-2.92), AE (MD, -4.34; 95%CI, -5.90~-2.78), ME (MD, -3.47; 95%CI, -4.95~-1.99), YG (MD, -2.07; 95%CI, -3.56~-0.57), and MT (MD, -1.68; 95%CI, -2.91~-0.46) demonstrated superior PSQI improvement compared to CG (Figure 4). Comparison of the adjusted funnel plot did not provide evidence of significant publication bias, as confirmed by Egger’s test (P = 0.744) (Additional document 1: Appendix 5.2). Heterogeneity, inaccessibility, and inconsistencies in the network meta-analyses were evaluated (Additional Reference 1: Appendix 6). In addition, direct comparisons of the PSQI scores were evaluated. (Additional Reference 1: Appendix 7.2).
Quality of life
A total of 17 (41, 42, 53, 59, 77, 93, 96, 99–108) studies evaluated FACT-B in 1372 participants. Seven interventions were included in the NMA (Figure 3C): CG, AE, ME, CBT, YG, SE, and OE. CTE (MD, 11.39; 95%CI, 4.11-18.66), YG (MD, 11.28; 95%CI, 1.63-20.93), and AE (MD, 9.34; 95%CI, 0.26~18.42) demonstrated superior FACT-B improvement compared with CG. (Figure 4C). The comparison of the adjusted funnel plots did not provide evidence of significant publication bias, as confirmed by Egger’s test (P = 0.365) (Additional document 1: Appendix 5.3). Heterogeneity, inaccessibility, and inconsistencies in network meta-analyses were also evaluated (Additional Reference 1: Appendix 6). In addition, direct comparisons of FACT-B were assessed (Additional Reference 1: Appendix 7.3).
Discussion
Breast cancer has the highest cancer incidence in women worldwide, and the survival rate of patients with breast cancer has been increasing. A range of side effects are often experienced by survivors of breast cancer, with CRF being a common side effect (109).
Several factors, including tumor stage, radiotherapy, chemotherapy, surgery, hormone therapy, radiation therapy dose, tumor burden, and the combination of these therapies, contribute to the development of CRF. Patients receiving cyclophosphamide, fluorouracil, adriamycin, or docetaxel experience more severe CRF than patients receiving paclitaxel alone (8, 110). An increase in the incidence of fatigue from 10% to 29% after treatment was observed in a cross-sectional study (111).
Furthermore, a patient’s CRF can be affected by factors such as family dysfunction, social support system, occupation, and hope level. Patients experiencing family dysfunction not only confront the physical pain induced by the disease and radiotherapy and chemotherapy but also endure the pressure arising from the family disorder, contributing to an increase in fatigue level (112). The onset of breast cancer and subsequent lifelong treatment impose medical burdens on patients, leading to emotional and role changes among some patient’s family members. This exacerbates the psychological burden and contributes to increased CRF (112). Sørensen HL et al. (113) discovered a close relationship between social support and physical and mental fatigue experienced by patients with breast cancer, with a stronger correlation observed for mental fatigue. Patients lacking social support face difficulties in receiving adequate support and assistance and struggle to effectively express sad emotions, leading to increased pressure on patients and a consequent worsening of fatigue. Yao Li et al. (114). found that farmers’ lower fatigue levels may be attributed to their low educational level, limited avenues for acquiring tumor-related knowledge, and higher expectations regarding disease prognosis. Furthermore, farmers may shoulder less social responsibility than patients with higher education, experiencing less social pressure, and exhibiting less noticeable fatigue. CRF has a tendency to persist and can result in dysfunction, reduced quality of life, and the emergence of negative emotions. Patients with breast cancer experience pain from CRF before or during treatment. Currently, a significant number of patients with breast cancer experience CRF, emphasizing the urgent need for its management.
Currently, numerous studies are focusing on improving CRF in breast cancer. This study conducted a literature search from 2001 to 2022, yielding 77 articles. Twelve various interventions (Aerobic exercise, Resistance training, Chinese traditional exercises, Other exercise, Multimodal exercise, Yoga, Stretching exercise, Music interventions, Cognitive behavioral therapy, Mindfulness training, Relaxation exercises, Control group) were analyzed to investigate their impact on patients with breast cancer and determine which intervention can effectively enhance CRF, alleviate depression, and improve quality of life in these patients.
The findings of this study indicate that CBT, CTE, AE, ME, MI, and YG were more effective than CG in improving CRF in patients with breast cancer. CBT can alter patients’ thinking, beliefs, and behaviors, correcting erroneous cognition and eliminating negative emotions through psychological treatment (115). Cognitive behavioral therapy can reduce CRF in patients with cancer through cognitive therapy, behavioral therapy, and psychological intervention. Clinical practice guidelines have recommended Cognitive behavioral therapy to reduce CRF in adults (116). The findings of this study are consistent with those of the traditional meta (117). In this study, we referred to Tai Chi, Qigong, and Baduanjin as Chinese traditional exercises. It was found that Chinese traditional exercises significantly improved CRF in patients with breast cancer compared to Control group. Tai Chi can regulate the nervous regions of the downstream stress response pathway by regulating the neuroendocrine system, including the autonomic nervous system and the hypothalamic-pituitary-adrenal axis. This regulation impacts the production of inflammatory factors (31, 118), leading to the downregulation of inflammatory factors, improvement in the inflammatory environment of patients’ tumors, and alleviation of CRF. Furthermore, Tai Chi is typically performed in groups, fostering a strong sense of community and social support among participating patients. They can share difficult everyday experiences and feel comfortable facing similar adversities. Additionally, social support can play a crucial role in buffering patients’ stress (119). Social support can enhance patients’ self-management ability, coping ability, and quality of life, including CRF (120). CTE regulates the respiratory system, enhances physiological function, promotes metabolism, and improves physical fitness, which can improve CRF in patients with breast cancer to a certain extent.
A relatively severe symptom burden caused by cancer diagnosis and treatment leads to patients being prone to sleep disorders (121). Sleep disorders affect more than 50% of patients with cancer, with some experiencing persistent and recurring sleep disorders within one year of completing treatment. Prolonged sleep disorders exacerbate patients’ pain, fatigue, psychological pain, and other symptoms, significantly affecting their quality of life and prognosis (122, 123).
This study discovered that Relaxation exercises, Music interventions, Aerobic exercise, and Multimodal exercise were more likely to improve the sleep quality of patients with breast cancer than Chinese traditional exercises, Other exercise, and Control group. Relaxation exercises regulates the function disturbed by tension stimulation, promotes muscle relaxation, reduces the arousal level of the cerebral cortex, and facilitates falling asleep through consciously repeated exercises of muscle tension and relaxation. Music interventions can affect the release of morphine peptides and other substances in the body and slow down negative emotions associated with sleep disorders, such as anxiety and depression, to improve sleep quality (117). Furthermore, Music interventions can regulate the body and mind of patients, inducing relaxation and guiding them into a relaxed and happy state, which contributes positively to stabilizing emotions and relieving pain. Relaxation exercises and Music interventions are also cost-effective and easy to practice. Using Relaxation exercises is recommended to improve sleep in patients with breast cancer and those experiencing sleep disorders. Moreover, this study observed that Chinese traditional exercises, Yoga, and Aerobic exercise were more effective than Control group in improving patients’ quality of life.
Study strengths and limitations
This review has several advantages. First, mesh meta-analysis was used to directly and indirectly compare various interventions. Notably, more accurate interventions were included and meticulously classified into 12 various interventions, with each being defined. The effects of various intervention methods on CRF, PSQI, and quality of life were examined, along with the investigation of additional intervention measures. The findings of this study can be used as an optimal reference.
However, certain limitations exist in this study. First, the duration, intensity, and frequency of the interventions were not considered. Second, the implementation quality of the blind approach in the included literature is not high, and the outcome indicators are all subjective, lacking objective indicators. A description of the biological parameters should be added. Third, only Chinese–English literature was included, which may have resulted in heterogeneity. Fourth, all the studies were small sample studies; therefore, it is recommended to conduct future studies with large samples. Finally, in this study, the effects of tumor stage, patient treatment, patient’s psychological status, and patient’s family situation on CRF were not considered, which will have a particular impact on the results of this study.
Conclusion
Evidence from systematic reviews and meta-analyses strongly recommends CBT for improving CRF in patients with breast cancer. RE and CTE are recommended to enhance the quality of sleep in patients with breast cancer. This study includes limited results, and it is recommended that future investigations include more studies to further validate the findings and select appropriate interventions based on the circumstances of patients with breast cancer.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Author contributions
YL: Writing – original draft, Writing – review & editing. LG: Data curation, Writing – original draft. RL: Data curation, Writing – original draft. JZ: Data curation, Software, Writing – original draft. ZZ: Data curation, Writing – original draft. SL: Writing – original draft, Data curation. XC: Supervision, Writing – original draft, Writing – review & editing. YC: Writing – review & editing, Supervision, Resources. TL: Writing – review & editing, Resources. JL: Writing – review & editing, Resources. ZW: Writing – review & editing, Supervision, Resources.
Funding Statement
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fonc.2024.1341927/full#supplementary-material
References
- 1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin (2022) 72:7–33. doi: 10.3322/caac.21708 [DOI] [PubMed] [Google Scholar]
- 2. Avis NE, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol (2005) 23:3322–30. doi: 10.1200/JCO.2005.05.130 [DOI] [PubMed] [Google Scholar]
- 3. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol (2000) 18:743–53. doi: 10.1200/JCO.2000.18.4.743 [DOI] [PubMed] [Google Scholar]
- 4. Ganz PA. Monitoring the physical health of cancer survivors: a survivorship-focused medical history. J Clin Oncol (2006) 24:5105–11. doi: 10.1200/JCO.2006.06.0541 [DOI] [PubMed] [Google Scholar]
- 5. Nowe E, Friedrich M, Leuteritz K, Sender A, Stöbel-Richter Y, Schulte T, et al. Cancer-related fatigue and associated factors in young adult cancer patients. J Adolesc Young Adult Oncol (2019) 8:297–303. doi: 10.1089/jayao.2018.0091 [DOI] [PubMed] [Google Scholar]
- 6. Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, et al. An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics. Biosci Trends (2018) 12:220–39. doi: 10.5582/bst.2018.01144 [DOI] [PubMed] [Google Scholar]
- 7. Bardwell WA, Ancoli-Israel S. Breast cancer and fatigue. Sleep Med Clin (2008) 3:61–71. doi: 10.1016/j.jsmc.2007.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen C, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol (2016) 27:965–74. doi: 10.1093/annonc/mdw099 [DOI] [PubMed] [Google Scholar]
- 9. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol (2001) 19:3385–91. doi: 10.1200/JCO.2001.19.14.3385 [DOI] [PubMed] [Google Scholar]
- 10. Phillips SM, McAuley E. Physical activity and fatigue in breast cancer survivors: a panel model examining the role of self-efficacy and depression. Cancer Epidemiol Biomarkers Prev (2013) 22:773–81. doi: 10.1158/1055-9965.EPI-12-0983 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Carlson MA, Fradgley EA, Bridge P, Taylor J, Morris S, Coutts E, et al. The dynamic relationship between cancer and employment-related financial toxicity: an in-depth qualitative study of 21 Australian cancer survivor experiences and preferences for support. Support Care Cancer (2022) 30:3093–103. doi: 10.1007/s00520-021-06707-7 [DOI] [PubMed] [Google Scholar]
- 12. Bøhn SH, Vandraas KF, Kiserud CE, Dahl AA, Thorsen L, Ewertz M, et al. Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivors. J Cancer Surviv (2022). doi: 10.1007/s11764-022-01202-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Tran TXM, Jung SY, Lee EG, Cho H, Cho J, Lee E, et al. Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15-year follow-up study. J Cancer Surviv (2023) 17:1416–26. doi: 10.1007/s11764-022-01165-4 [DOI] [PubMed] [Google Scholar]
- 14. Dong B, Xie C, Jing X, Lin L, Tian L. Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis. Breast Cancer Res Treat (2019) 177:5–16. doi: 10.1007/s10549-019-05278-w [DOI] [PubMed] [Google Scholar]
- 15. Gray L, Sindall P, Pearson SJ. Does resistance training ameliorate cancer-related fatigue in cancer survivors? A systematic review with meta-analysis. Disabil Rehabil (2023) 1–10. doi: 10.1080/09638288.2023.2226408 [DOI] [PubMed] [Google Scholar]
- 16. Olsson Möller U, Beck I, Rydén L, Malmström M. A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews. BMC Cancer (2019) 19:472. doi: 10.1186/s12885-019-5648-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Invernizzi M, de Sire A, Lippi L, Venetis K, Sajjadi E, Gimigliano F, et al. Impact of rehabilitation on breast cancer related fatigue: A pilot study. Front Oncol (2020) 10:556718. doi: 10.3389/fonc.2020.556718 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Penna F, Ballarò R, Costelli P. The redox balance: A target for interventions against muscle wasting in cancer cachexia? Antioxid Redox Signal (2020) 33:542–58. doi: 10.1089/ars.2020.8041 [DOI] [PubMed] [Google Scholar]
- 19. Idorn M, Thor Straten P. Exercise and cancer: from "healthy" to "therapeutic"? Cancer Immunol Immunother (2017) 66:667–71. doi: 10.1007/s00262-017-1985-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Bafeta A, Trinquart L, Seror R, Ravaud P. Reporting of results from network meta-analyses: methodological systematic review. Bmj (2014) 348:g1741. doi: 10.1136/bmj.g1741 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Wu PY, Huang KS, Chen KM, Chou CP, Tu YK. Exercise, nutrition, and combined exercise and nutrition in older adults with sarcopenia: A systematic review and network meta-analysis. Maturitas (2021) 145:38–48. doi: 10.1016/j.maturitas.2020.12.009 [DOI] [PubMed] [Google Scholar]
- 22. Liu YC, Hung TT, Konara Mudiyanselage SP, Wang CJ, Lin MF. Beneficial exercises for cancer-related fatigue among women with breast cancer: A systematic review and network meta-analysis. Cancers (Basel) (2022) 15(1):151. doi: 10.3390/cancers15010151 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 4:1. doi: 10.1186/2046-4053-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Kali A, Srirangaraj S. EndNote as document manager for summative assessment. J Postgrad Med (2016) 62:124–5. doi: 10.4103/0022-3859.174158 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Meneses-Echávez JF, González-Jiménez E, Ramírez-Vélez R. Supervised exercise reduces cancer-related fatigue: a systematic review. J Physiother (2015) 61:3–9. doi: 10.1016/j.jphys.2014.08.019 [DOI] [PubMed] [Google Scholar]
- 26. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj (2011) 343:d5928. doi: 10.1136/bmj.d5928 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Jardim PSJ, Rose CJ, Ames HM, Echavez JFM, Van de Velde S, Muller AE. Automating risk of bias assessment in systematic reviews: a real-time mixed methods comparison of human researchers to a machine learning system. BMC Med Res Methodol (2022) 22:167. doi: 10.1186/s12874-022-01649-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Rücker G, Schwarzer G, Krahn U, König J. netmeta: Network meta-analysis with R.2018 . Available at: https://cran.r-project.org/web/packages/netmeta/index.html.
- 29. R Development Core Team . R. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; (2017). Available at: http://www.R-project.org. [Google Scholar]
- 30. Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol (2015) 15:58. doi: 10.1186/s12874-015-0060-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Fronza MG, Baldinotti R, Fetter J, Rosa SG, Sacramento M, Nogueira CW, et al. Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: The role of blood-brain barrier permeability, NF-κB signaling, and microglial activation. Brain Behav Immun (2022) 99:177–91. doi: 10.1016/j.bbi.2021.10.002 [DOI] [PubMed] [Google Scholar]
- 32. Gokal K, Wallis D, Ahmed S, Boiangiu I, Kancherla K, Munir F. Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial. Support Care Cancer (2016) 24:1139–66. doi: 10.1007/s00520-015-2884-5 [DOI] [PubMed] [Google Scholar]
- 33. Pinto BM, Frierson GM, Rabin C, Trunzo JJ, Marcus BH. Home-based physical activity intervention for breast cancer patients. J Clin Oncol (2005) 23:3577–87. doi: 10.1200/JCO.2005.03.080 [DOI] [PubMed] [Google Scholar]
- 34. Mock V, Frangakis C, Davidson NE, Ropka ME, Pickett M, Poniatowski B, et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology (2005) 14:464–77. doi: 10.1002/pon.863 [DOI] [PubMed] [Google Scholar]
- 35. Husebø AM, Dyrstad SM, Mjaaland I, Søreide JA, Bru E. Effects of scheduled exercise on cancer-related fatigue in women with early breast cancer. ScientificWorldJournal (2014) 2014:271828. doi: 10.1155/2014/271828 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Mock V, Pickett M, Ropka ME, Muscari Lin E, Stewart KJ, Rhodes VA, et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract (2001) 9:119–27. doi: 10.1046/j.1523-5394.2001.009003119.x [DOI] [PubMed] [Google Scholar]
- 37. Wang YJ, Boehmke M, Wu YW, Dickerson SS, Fisher N. Effects of a 6-week walking program on Taiwanese women newly diagnosed with early-stage breast cancer. Cancer Nurs (2011) 34:E1–13. doi: 10.1097/NCC.0b013e3181e4588d [DOI] [PubMed] [Google Scholar]
- 38. Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K. Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. Int J Cancer (2015) 137:471–80. doi: 10.1002/ijc.29383 [DOI] [PubMed] [Google Scholar]
- 39. Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, et al. Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Ann Oncol (2014) 25:2237–43. doi: 10.1093/annonc/mdu374 [DOI] [PubMed] [Google Scholar]
- 40. Qiong H, Willow, Shuangyan H, Minghui Z, Simin H, Hui X. Study on the influence of eight forms of Taijiquan on cancer-induced fatigue in patients with breast cancer. J Guangxi Univ Chin Med (2019) 22:30–4. doi: 10.3969/j.issn.2095-4441.2019.04.011 [DOI] [Google Scholar]
- 41. liu Y, Qiong H, Hui X, Xianhua Q, Ligang W, Liuyin C, et al. Observation of curative effect of simple Taijiquan on cancer-induced fatigue in patients with breast cancer and influence of inflammatory factors. J Guizhou Univ Chin Med (2022) 44:29–34. [Google Scholar]
- 42. Hui RU, Zhou Z, Jianfeng S. Effect observation of social support combined with Taijiquan exercise in elderly patients with breast cancer after surgery. Nurs Pract Res (2022) 19:1268–72. doi: 10.3969/j.issn.1672-9676.2022.09.002 [DOI] [Google Scholar]
- 43. Rong X, Ruijun L, Wenlin C, Good A. Effects of dance exercise therapy on cancer fatigue and nutritional status in young and middle-aged breast cancer patients during chemotherapy. Chin J Pract Nurs (2022) 38:1074–9. doi: 10.3760/cma.j.cn211501-20210609-01636 [DOI] [Google Scholar]
- 44. Ying X. Effect of home aerobic exercise on cancer-related fatigue in breast cancer outpatient patients undergoing chemotherapy. Hainan Med (2012) 23:145–7. doi: 10.3969/j.issn.1003-6350.2012.19.064 [DOI] [Google Scholar]
- 45. Nan H, Grass P, Xiaoyun K, Libin G. Nursing study on the influence of aerobic exercise on cancer-induced fatigue in patients with breast cancer. Nurs Pract Res (2013) 10:4–6. doi: 10.3969/j.issn.1672-9676.2013.12.002 [DOI] [Google Scholar]
- 46. Mijwel S, Backman M, Bolam KA, Jervaeus A, Sundberg CJ, Margolin S, et al. Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial. Breast Cancer Res Treat (2018) 168:79–93. doi: 10.1007/s10549-017-4571-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Cohen J, Rogers WA, Petruzzello S, Trinh L, Mullen SP. Acute effects of aerobic exercise and relaxation training on fatigue in breast cancer survivors: A feasibility trial. Psychooncology (2021) 30:252–9. doi: 10.1002/pon.5561 [DOI] [PubMed] [Google Scholar]
- 48. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol (2007) 25:4396–404. doi: 10.1200/JCO.2006.08.2024 [DOI] [PubMed] [Google Scholar]
- 49. Moadel AB, Shah C, Wylie-Rosett J, Harris MS, Patel SR, Hall CB, et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. J Clin Oncol (2007) 25:4387–95. doi: 10.1200/JCO.2006.06.6027 [DOI] [PubMed] [Google Scholar]
- 50. Bower JE, Garet D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, et al. Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial. Cancer (2012) 118:3766–75. doi: 10.1002/cncr.26702 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Vadiraja HS, Rao RM, Nagarathna R, Nagendra HR, Patil S, Diwakar RB, et al. Effects of yoga in managing fatigue in breast cancer patients: A randomized controlled trial. Indian J Palliat Care (2017) 23:247–52. doi: 10.4103/IJPC.IJPC_95_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Vardar Yağlı N, Şener G, Arıkan H, Sağlam M, İnal İnce D, Savcı S, et al. Do yoga and aerobic exercise training have impact on functional capacity, fatigue, peripheral muscle strength, and quality of life in breast cancer survivors? Integr Cancer Ther (2015) 14:125–32. doi: 10.1177/1534735414565699 [DOI] [PubMed] [Google Scholar]
- 53. Cramer H, Rabsilber S, Lauche R, Kümmel S, Dobos G. Yoga and meditation for menopausal symptoms in breast cancer survivors-A randomized controlled trial. Cancer (2015) 121:2175–84. doi: 10.1002/cncr.29330 [DOI] [PubMed] [Google Scholar]
- 54. Vadiraja SH, Rao MR, Nagendra RH, Nagarathna R, Rekha M, Vanitha N, et al. Effects of yoga on symptom management in breast cancer patients: A randomized controlled trial. Int J Yoga (2009) 2:73–9. doi: 10.4103/0973-6131.60048 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Chaoul A, Milbury K, Spelman A, Basen-Engquist K, Hall MH, Wei Q, et al. Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy. Cancer (2018) 124:36–45. doi: 10.1002/cncr.30938 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Lötzke D, Wiedemann F, Rodrigues Recchia D, Ostermann T, Sattler D, Ettl J, et al. Iyengar-yoga compared to exercise as a therapeutic intervention during (Neo)adjuvant therapy in women with stage I-III breast cancer: health-related quality of life, mindfulness, spirituality, life satisfaction, and cancer-related fatigue. Evid Based Complement Alternat Med (2016) 2016:5931816. doi: 10.1155/2016/5931816 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Banasik J, Williams H, Haberman M, Blank SE, Bendel R. Effect of Iyengar yoga practice on fatigue and diurnal salivary cortisol concentration in breast cancer survivors. J Am Acad Nurse Pract (2011) 23:135–42. doi: 10.1111/j.1745-7599.2010.00573.x [DOI] [PubMed] [Google Scholar]
- 58. Strunk MA, Zopf EM, Steck J, Hamacher S, Hallek M, Baumann FT. Effects of kyusho jitsu on physical activity-levels and quality of life in breast cancer patients. In Vivo (2018) 32:819–24. doi: 10.21873/invivo.11313 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Danhauer SC, Mihalko SL, Russell GB, Campbell CR, Felder L, Daley K, et al. Restorative yoga for women with breast cancer: findings from a randomized pilot study. Psychooncology (2009) 18:360–8. doi: 10.1002/pon.1503 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Jong MC, Boers I, Schouten van der Velden AP, Meij SV, Göker E, Timmer-Bonte A, et al. A randomized study of yoga for fatigue and quality of life in women with breast cancer undergoing (Neo) adjuvant chemotherapy. J Altern Complement Med (2018) 24:942–53. doi: 10.1089/acm.2018.0191 [DOI] [PubMed] [Google Scholar]
- 61. Guofei W, Shuhong W, Pinglan J, Chun Z. Intervention effect of yoga on cancer-induced fatigue in patients with breast cancer undergoing chemotherapy. J Cent South Univ (Medical) (2014) 39:1077–82. doi: 10.11817/j.issn.1672-7347.2014.10.016 [DOI] [Google Scholar]
- 62. Jinfang Z. Effect of yoga combined with music relaxation training on cancer-induced fatigue in patients with breast cancer undergoing chemotherapy. Electronic J Pract Clin Nurs (2017) 2:1–2. doi: 10.3969/j.issn.2096-2479.2017.19.001 [DOI] [Google Scholar]
- 63. Dongyang X, Mei W, Hao W, Jie L, Jia L, Zhongru C. Effect of yoga combined with music relaxation training on cancer-induced fatigue in patients with breast cancer undergoing chemotherapy. Chin J Modern Nurs (2017) 23:184–7. doi: 10.3760/cma.j.issn.1674-2907.2017.02.009 [DOI] [Google Scholar]
- 64. Min Y, Yanni D, Jing X, Effect W, Lan L, Jing Z. Application effect of exercise intervention on cancer-induced fatigue in patients with breast cancer undergoing chemotherapy. Clin Med Res Pract (2020) 5:161–3. doi: 10.19347/j.cnki.2096-1413.202031057 [DOI] [Google Scholar]
- 65. Jiali L. Effect of exercise intervention on cancer-induced fatigue and sleep quality in patients with breast cancer undergoing chemotherapy. World J Sleep Med (2018) 5:792–4. doi: 10.3969/j.issn.2095-7130.2018.07.013 [DOI] [Google Scholar]
- 66. Xuanzhi L, Huiying L, Huizhen H, Liangsheng S. Effect of exercise intervention on cancer-induced fatigue and sleep quality in patients with breast cancer undergoing chemotherapy. World J Sleep Med (2019) 6:1311–2. doi: 10.3969/j.issn.2095-7130.2019.09.057 [DOI] [Google Scholar]
- 67. Lina L, Lihua Z, Hongxia F, Xiangyun S. Effect of exercise intervention on cancer-related fatigue and sleep quality in patients with breast cancer undergoing chemotherapy. Gen Nurs (2015) 13:2190–1. doi: 10.3969/j.issn.1674-4748.2015.22.030 [DOI] [Google Scholar]
- 68. Xin Y. Observation on the effect of aerobic exercise on cancer-induced fatigue in patients with breast cancer treated with radiotherapy. Chin Med Guide (2020) 18:95–6. [Google Scholar]
- 69. Li C, Jie Z, Yan W, Yamei W, Hongfang L, Xiaomei L. Effect of music therapy combined with aerobic exercise on sleep quality in patients with chemotherapy after radical breast cancer surgery. Nurs Manage China (2016) 16:989–94. doi: 10.3969/j.issn.1672-1756.2016.07.030 [DOI] [Google Scholar]
- 70. Ximei Y. Effects of rehabilitation yoga exercises combined with emotional nursing on cancer-related fatigue in patients with breast cancer. Chin convalescent Med (2021) 30:1185–9. doi: 10.13517/j.cnki.ccm.2021.11.020 [DOI] [Google Scholar]
- 71. Li Y. To analyze the effects of exercise intervention on cancer-induced fatigue and sleep quality in patients with breast cancer undergoing chemotherapy. World J Sleep Med (2022) 9:1414–6. doi: 10.3969/j.issn.2095-7130.2022.08.011 [DOI] [Google Scholar]
- 72. Jiang Z, Yan L, Wenhui L, Xijuan Z, Zhengting C, Qiongyao G, et al. Effects of bedtime music therapy on sleep quality and cancer-related fatigue in patients with breast cancer radiotherapy. J Kunming Med Univ (2020) 41:173–8. doi: 10.12259/j.issn.2095-610X.S20201248 [DOI] [Google Scholar]
- 73. Bolam KA, Mijwel S, Rundqvist H, Wengström Y. Two-year follow-up of the OptiTrain randomised controlled exercise trial. Breast Cancer Res Treat (2019) 175:637–48. doi: 10.1007/s10549-019-05204-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Park S, Sato Y, Takita Y, Tamura N, Ninomiya A, Kosugi T, et al. Mindfulness-based cognitive therapy for psychological distress, fear of cancer recurrence, fatigue, spiritual well-being, and quality of life in patients with breast cancer-A randomized controlled trial. J Pain Symptom Manage (2020) 60:381–9. doi: 10.1016/j.jpainsymman.2020.02.017 [DOI] [PubMed] [Google Scholar]
- 75. Paulo TRS, Rossi FE, Viezel J, Tosello GT, Seidinger SC, Simões RR, et al. The impact of an exercise program on quality of life in older breast cancer survivors undergoing aromatase inhibitor therapy: a randomized controlled trial. Health Qual Life Outcomes (2019) 17:17. doi: 10.1186/s12955-019-1090-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Yanbing W, Zhongguo C, Li Z, Wanping L, Jianling Z, Zhonghai W, et al. Intervention effect of Baduanjin and pattern-doudou diabolo on breast cancer patients after surgery. J Hebei North Univ (Natural Sci Edition) (2022) 38:16–19+22. [Google Scholar]
- 77. Wei X, Yuan R, Yang J, Zheng W, Jin Y, Wang M, et al. Effects of Baduanjin exercise on cognitive function and cancer-related symptoms in women with breast cancer receiving chemotherapy: a randomized controlled trial. Support Care Cancer (2022) 30:6079–91. doi: 10.1007/s00520-022-07015-4 [DOI] [PubMed] [Google Scholar]
- 78. SChad F, Rieser T, Becker S, Groß J, Matthes H, Oei SL, et al. Efficacy of tango argentino for cancer-associated fatigue and quality of life in breast cancer survivors: A randomized controlled trial. Cancers (Basel) (2023) 15(11):2920. doi: 10.3390/cancers15112920 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Liao J, Chen Y, Cai L, Wang K, Wu S, Wu L, et al. Baduanjin's impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial. Front Oncol (2022) 12:807531. doi: 10.3389/fonc.2022.807531 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Boing L, Baptista F, Pereira GS, Sperandio FF, Moratelli J, Cardoso AA, et al. Benefits of belly dance on quality of life, fatigue, and depressive symptoms in women with breast cancer - A pilot study of a non-randomised clinical trial. J Bodyw Mov Ther (2018) 22:460–6. doi: 10.1016/j.jbmt.2017.10.003 [DOI] [PubMed] [Google Scholar]
- 81. Naraphong W, Lane A, Schafer J, Whitmer K, Wilson BRA. Exercise intervention for fatigue-related symptoms in Thai women with breast cancer: A pilot study. Nurs Health Sci (2015) 17:33–41. doi: 10.1111/nhs.12124 [DOI] [PubMed] [Google Scholar]
- 82. Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Nicassio P, Ganz PA, et al. Tai chi chih compared with cognitive behavioral therapy for the treatment of insomnia in survivors of breast cancer: A randomized, partially blinded, noninferiority trial. J Clin Oncol (2017) 35:2656–65. doi: 10.1200/JCO.2016.71.0285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Chen Z, Meng Z, Milbury K, Bei W, Zhang Y, Thornton B, et al. Qigong improves quality of life in women undergoing radiotherapy for breast cancer: results of a randomized controlled trial. Cancer (2013) 119:1690–8. doi: 10.1002/cncr.27904 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Huang SM, Tseng LM, Chien LY, Tai CJ, Chen PH, Hung CT, et al. Effects of non-sporting and sporting qigong on frailty and quality of life among breast cancer patients receiving chemotherapy. Eur J Oncol Nurs (2016) 21:257–65. doi: 10.1016/j.ejon.2015.10.012 [DOI] [PubMed] [Google Scholar]
- 85. Xin C, Huan Z, Ling L. A study of mindfulness training intervention on cancer-related fatigue in breast cancer patients after chemotherapy. Chongqing Med Sci (2016) 45:2953–5. doi: 10.3969/j.issn.1671-8348.2016.21.022 [DOI] [Google Scholar]
- 86. Zhen JJ, Ping MX. Effects of mindfulness-based stress reduction training on perceived stress and cancer-related fatigue in patients with advanced breast cancer. Clin Educ Gen Pract (2019) 17:575–6. doi: 10.13558/j.cnki.issn1672-3686.2019.03.033 [DOI] [Google Scholar]
- 87. Fanbenben. Effects of mindfulness-based stress reduction therapy on cancer-related fatigue and sleep quality in patients with breast cancer undergoing chemotherapy. Chin school doctor (2021) 35:111–3. [Google Scholar]
- 88. Jinmei W, Huiyuan M, Yalan S. Effects of mindfulness relaxation training on fear of cancer recurrence, cancer-related fatigue and sleep quality in patients with breast cancer. Oncol Clin Rehabil China (2021) 28:228–33. [Google Scholar]
- 89. Brown CH, Max L, LaFlam A, Kirk L, Gross A, Arora R, et al. The association between preoperative frailty and postoperative delirium after cardiac surgery. Anesth Analgesia (2016) 123:430–5. doi: 10.1213/ANE.0000000000001271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Reich RR, Lengacher CA, Kip KE, Shivers SC, Schell MJ, Shelton MM, et al. Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients. Biol Res Nurs (2014) 16:429–37. doi: 10.1177/1099800413519494 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Rahmani S, Talepasand S. The effect of group mindfulness - based stress reduction program and conscious yoga on the fatigue severity and global and specific life quality in women with breast cancer. Med J Islam Repub Iran (2015) 29:175. [PMC free article] [PubMed] [Google Scholar]
- 92. Lengacher CA, Reich RR, Paterson CL, Ramesar S, Park JY, Alinat C, et al. Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: A randomized controlled trial. J Clin Oncol (2016) 34:2827–34. doi: 10.1200/JCO.2015.65.7874 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Daley AJ, Crank H, Saxton JM, Mutrie N, Coleman R, Roalfe A. Randomized trial of exercise therapy in women treated for breast cancer. J Clin Oncol (2007) 25:1713–21. doi: 10.1200/JCO.2006.09.5083 [DOI] [PubMed] [Google Scholar]
- 94. Yingying W. Effect of Taijiquan on cancer-related fatigue and quality of life in middle-aged and elderly patients with breast cancer after surgery thesis]. Anhui Normal University; (2017). [Google Scholar]
- 95. Jing L. Effects of yoga combined with meditation training on cancer-related fatigue and negative emotions in patients with breast cancer undergoing chemotherapy. Clin Nurs China (2019) 11:284–7. doi: 10.3969/j.issn.1674-3768.2019.04.003 [DOI] [Google Scholar]
- 96. Ping X. Application effect of music therapy combined with aerobic exercise in postoperative chemotherapy for breast cancer patients. Chin Contemp Med (2019) 26:214–7. doi: 10.3969/j.issn.1674-4721.2019.14.064 [DOI] [Google Scholar]
- 97. Taohua Y, Weiwei F, Guangling H. Effects of relaxation training combined with aerobic exercise on psychological adjustment, cancer-related fatigue and sleep quality in patients with breast cancer. Guangdong Med (2020) 41:1373–7. doi: 10.13820/j.cnki.gdyx.20191342 [DOI] [Google Scholar]
- 98. Ling ZY. Study of Baduanjin alleviating cancer-related fatigue in patients with breast cancer thesis]. Qingdao University; (2021). [Google Scholar]
- 99. Liu W, Liu J, Ma L, Chen J. Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial. J Cancer Res Clin Oncol (2022) 148:2549–60. doi: 10.1007/s00432-022-04167-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Stan DL, Croghan KA, Croghan IT, Jenkins SM, Sutherland SJ, Cheville AL, et al. Randomized pilot trial of yoga versus strengthening exercises in breast cancer survivors with cancer-related fatigue. Support Care Cancer (2016) 24:4005–15. doi: 10.1007/s00520-016-3233-z [DOI] [PubMed] [Google Scholar]
- 101. Rogers LQ, Courneya KS, Anton PM, Hopkins-Price P, Verhulst S, Vicari SK, et al. Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial. Breast Cancer Res Treat (2015) 149:109–19. doi: 10.1007/s10549-014-3216-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Sweeney FC, et al. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial. Breast Cancer Res (2018) 20:124. doi: 10.1186/s13058-018-1051-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103. Cuifeng J, Lili W, Bei W. Effect of yoga exercise on cancer-induced fatigue and quality of life in breast cancer patients during chemotherapy. Integrated Nurs (Chinese Western Medicine) (2017) 3:12–5. doi: 10.11997/nitcwm.201704004 [DOI] [Google Scholar]
- 104. Ping D, Zheng Z, Yao L, Li F. Clinical effect of aerobic exercise on oxygen carrying capacity and quality of life of breast cancer patients during chemotherapy. Rehabil China (2019) 34:596–8. doi: 10.3870/zgkf.2019.11.010 [DOI] [Google Scholar]
- 105. Qun L, Fang WL, Xin Z. Effect of Baduanjin on mood and quality of life of patients undergoing radiotherapy after radical breast cancer surgery. Gen Nurs (2017) 15:2257–9. doi: 10.3969/j.issn.1674-4748.2017.18.033 [DOI] [Google Scholar]
- 106. Odynets T, Briskin Y, Todorova V. Effects of different exercise interventions on quality of life in breast cancer patients: A randomized controlled trial. Integr Cancer Ther (2019) 18:1534735419880598. doi: 10.1177/1534735419880598 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Fong SS, Ng SS, Luk WS, Chung JW, Chung LM, Tsang WW, et al. Shoulder mobility, muscular strength, and quality of life in breast cancer survivors with and without tai chi qigong training. Evid Based Complement Alternat Med (2013) 2013:787169. doi: 10.1155/2013/787169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Loh SY, Lee SY, Murray L. The Kuala Lumpur Qigong trial for women in the cancer survivorship phase-efficacy of a three-arm RCT to improve QOL. Asian Pac J Cancer Prev (2014) 15:8127–34. doi: 10.7314/APJCP.2014.15.19.8127 [DOI] [PubMed] [Google Scholar]
- 109. Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-related fatigue, version 2. 2015. J Natl Compr Canc Netw (2015) 13:1012–39. doi: 10.6004/jnccn.2015.0122 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110. Lundh Hagelin C, Wengström Y, Fürst CJ. Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer-a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer (2009) 17:519–26. doi: 10.1007/s00520-008-0502-5 [DOI] [PubMed] [Google Scholar]
- 111. Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer (2012) 118:2261–9. doi: 10.1002/cncr.27475 [DOI] [PubMed] [Google Scholar]
- 112. Junwei M, Yimei Z, Shan Y, Ping L. Longitudinal study of cancer-induced fatigue trajectories and influencing factors in breast cancer patients during chemotherapy. Chin J Pract Nurs (2022) 38:1121–9. doi: 10.3760/cma.j.cn211501-20210929-02734 [DOI] [Google Scholar]
- 113. Sørensen HL, Schjølberg TK, Småstuen MC, Utne I. Social support in early-stage breast cancer patients with fatigue. BMC Womens Health (2020) 20:243. doi: 10.1186/s12905-020-01106-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Li Y, Yan W, Yang Y, Shurui J, Key H. Longitudinal study on the trajectory and influencing factors of cancer-induced fatigue in patients with lung cancer undergoing chemotherapy. Nurs Manage China (2022) 29:795–802. doi: 10.12025/j.issn.1008-6358.2022.20220271 [DOI] [Google Scholar]
- 115. An H, He RH, Zheng YR, Tao R. Cognitive-behavioral therapy. Adv Exp Med Biol (2017) 1010:321–9. doi: 10.1007/978-981-10-5562-1_16 [DOI] [PubMed] [Google Scholar]
- 116. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol (2014) 32:1840–50. doi: 10.1200/JCO.2013.53.4495 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Liping T, Xiaoqing W, Fan T, Shaowen Z, Yuzhu Z, Qianjun C. Cognitive behavioral therapy improves cancer-related fatigue in cancer patients: a meta-analysis. Chongqing Med Sci (2020) 49:3985–90. doi: 10.3969/j.issn.1671-8348.2020.23.028 [DOI] [Google Scholar]
- 118. O'Higgins CM, Brady B, O'Connor B, Walsh D, Reilly RB. The pathophysiology of cancer-related fatigue: current controversies. Support Care Cancer (2018) 26:3353–64. doi: 10.1007/s00520-018-4318-7 [DOI] [PubMed] [Google Scholar]
- 119. Yeh GY, Chan CW, Wayne PM, Conboy L. The impact of tai chi exercise on self-efficacy, social support, and empowerment in heart failure: insights from a qualitative sub-study from a randomized controlled trial. PloS One (2016) 11:e0154678. doi: 10.1371/journal.pone.0154678 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120. Yan D, Jing L, Lizhen L, Jingli F. Effects of social support, coping style and depression on quality of life in patients with pulmonary tuberculosis based on structural equation model. Int J Nurs Sci (2022) 41:2028–32. doi: 10.3760/cma.j.cn221370-20200818-00523 [DOI] [Google Scholar]
- 121. Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw (2021) 19:329–59. doi: 10.6004/jnccn.2021.0012 [DOI] [PubMed] [Google Scholar]
- 122. Reynolds-Cowie P, Fleming L. Living with persistent insomnia after cancer: A qualitative analysis of impact and management. Br J Health Psychol (2021) 26:33–49. doi: 10.1111/bjhp.12446 [DOI] [PubMed] [Google Scholar]
- 123. Steel JL, Terhorst L, Collins KP, Geller DA, Vodovotz Y, Kim J, et al. Prospective analyses of cytokine mediation of sleep and survival in the context of advanced cancer. Psychosom Med (2018) 80:483–91. doi: 10.1097/PSY.0000000000000579 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.



